⌘K

16:05:00·478d

PRReleasevia Quantisnow

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

ByQuantisnow·Wall Street's wire, on your screen.

ADMA· ADMA Biologics Inc

Health Care

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Raymond James resumed coverage on ADMA Biologics with a new price target
ADMA Biologics Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Director Grossman Jerrold B bought $50,624 worth of shares (6,400 units at $7.91), increasing direct ownership by 1% to 520,284 units (SEC Form 4)
Director Grossman Jerrold B bought $100,125 worth of shares (12,500 units at $8.01), increasing direct ownership by 2% to 513,884 units (SEC Form 4)
Director Grossman Jerrold B bought $100,125 worth of shares (12,500 units at $8.01), increasing direct ownership by 3% to 501,384 units (SEC Form 4)